Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
- Web page: http://www.inmi.it/
- Country: Italy
- project . 2020 - 2022Funder: EC Project Code: 101003544Overall Budget: 2,547,150 EURFunder Contribution: 2,547,150 EUROpen Access mandate for PublicationsPartners: ICN2, UB, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, AMU
The recent outbreak in China caused by the emerging nCoV virus is challenging the level of global readiness from governments, public organizations and community to face and manage both its social and health consequences. Once the emergence is recognized and identified, ...
- project . 2015 - 2017Funder: EC Project Code: 115844Overall Budget: 2,260,100 EURFunder Contribution: 2,260,100 EUROpen Access mandate for PublicationsPartners: Mendelova univerzita v Brne, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, GNA BIOSOLUTIONS GMBH, EMERGENCY ONG ONLUS
There is an urgent need for fast and accurate diagnostic tests in the current Ebola crisis. The rapid diagnosis of EVD during early and late stage of infection is a decisive step for risk assessment and for guidance to physicians to take the necessary decisions to limit...
- project . 2020 - 2024Funder: EC Project Code: 101005111Overall Budget: 3,747,600 EURFunder Contribution: 3,435,100 EUROpen Access mandate for PublicationsPartners: AIT, GNA BIOSOLUTIONS GMBH, BMVg, MicroLIQUID (Spain), Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
The DECISION consortium is developing a new class of diagnostic platform that will transform the fight against pandemics. The low-cost, miniaturised, disposable molecular diagnostic platform will allow for patient testing virtually anywhere, within a few minutes, with l...
- project . 2020 - 2022Funder: EC Project Code: 101005075Overall Budget: 1,819,960 EURFunder Contribution: 784,470 EUROpen Access mandate for PublicationsPartners: AMU, UNIVERSITA DI CORSICA PASQUALE PAOLI, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, BG Research Ltd, BIOTRONICS LTD
This project focuses on rapid (40min), simple, Point-of-Need COVID-19 testing, e.g. surgery/home (via first responders)/transit points of entry. BG Research (BGR) has developed direct from crude sample detection of viral pathogens – the QuRapID-XF technology, removing r...
- project . 2017 - 2020Funder: EC Project Code: 768889Overall Budget: 3,858,770 EURFunder Contribution: 3,858,770 EUROpen Access mandate for PublicationsPartners: MultiD Analyses (Sweden), DODOMA REGION, Tataa Biocenter (Sweden), GNA BIOSOLUTIONS GMBH, FHG, LU, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
The overall goal of this project is to bring the unique, ultra-fast Local Heating PCR technology and its current lab-proven prototype instruments from TRL 4 up to TRL 6 into clinical demonstration in tuberculosis centers in Italy, Latvia, and Tanzania. This will imply a...
Powered by OpenAIRE Research Graph